Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Lowers Price Target to $25

Benzinga · 3d ago
Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and lowers the price target from $28 to $25.